BCR and diffuse large B-cell lymphoma: In addition, IGK/LV SHMhigh in GCB-DLBCL could be a biomarker for stronger BCR affinity and higher B-cell proliferation propensity [3, 14], therefore synergizing with unfavorable BCL2-R which enhanced cell survival.